Does USTEKINUMAB Cause Type 2 diabetes mellitus? 2,351 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 2,351 reports of Type 2 diabetes mellitus have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 2.8% of all adverse event reports for USTEKINUMAB.
2,351
Reports of Type 2 diabetes mellitus with USTEKINUMAB
2.8%
of all USTEKINUMAB reports
1,579
Deaths
1,541
Hospitalizations
How Dangerous Is Type 2 diabetes mellitus From USTEKINUMAB?
Of the 2,351 reports, 1,579 (67.2%) resulted in death, 1,541 (65.5%) required hospitalization, and 1,669 (71.0%) were considered life-threatening.
Is Type 2 diabetes mellitus Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 2,351 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Type 2 diabetes mellitus?
ATORVASTATIN (7,556)
ADALIMUMAB (3,516)
PREDNISONE (3,484)
METHOTREXATE (3,465)
RITUXIMAB (3,318)
TOCILIZUMAB (3,145)
ABATACEPT (3,074)
LEFLUNOMIDE (3,033)
ALENDRONATE (3,002)
DICLOFENAC (2,974)
Which USTEKINUMAB Alternatives Have Lower Type 2 diabetes mellitus Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE